Myfembree 72974-0415
Generic: Relugolix, Estradiol Hemihydrate, And Norethindrone Acetate
Product NDC
72974-0415- Manufacturer
- Sumitomo Pharma America, Inc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 26, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA214846
Need to source Myfembree? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Estradiol Hemihydrate | 1 mg/1 |
| Norethindrone Acetate | .5 mg/1 |
| Relugolix | 40 mg/1 |
Drug Class
Gonadotropin Releasing Hormone Receptor Antagonist [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2B6 Inducers [MoA]
Packaging Options(2)
28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-01)
7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-99)
External Resources